PHARMACEUTICALS: Dramatic Payment Drops Set For Common Drugs
New rates could hit hardest in smaller offices.Even though the Centers for Medicare and Medicaid Services has been collecting information from physicians who say they can't obtain drugs at the rock-bottom prices Medicare has been paying, the newest numbers don't show much improvement for payments. CMS released the latest drug rates, based on 106 percent of Average Sales Price data, and many chemotherapy drugs were treated to sharp decreases.The hardest hit include Cytarabine, which dropped around 38 percent; Etoposide, which dropped around 33 percent; and Carboplatin injection, which fell to around 31 percent. CMS insisted that...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: